Scynexis (SCYX) EBIT Margin (2013 - 2025)
Scynexis (SCYX) reported EBIT Margin of 132.95% for Q4 2025, up 95720.0% on a YoY basis from N/an in Q4 2024, and up 105.28% quarter-over-quarter from 2516.47% in Q3 2025.
Scynexis (SCYX) EBIT Margin (2013 - 2025) Analysis & Trends
Scynexis has reported EBIT Margin for 12 years, with the latest figure at 132.95% in Q4 2025.
- For the quarter ending Q4 2025, EBIT Margin rose 95720.0% year-over-year to 132.95%; the trailing twelve-month figure through Mar 2026 stood at 49.72% (up 132746.0% YoY), and the FY2025 full-year result was 8.77%, up 98208.0% from the prior year.
- EBIT Margin for Q4 2025 stood at 132.95%, up from 2516.47% in the prior quarter.
- The five-year high for EBIT Margin was 5152.43% in Q4 2021, with the low at 3767.64% in Q3 2021.
- Historically, EBIT Margin has averaged 977.09% across 5 years, with a median of 945.31% in 2023.
- The largest YoY upside for EBIT Margin was 236744 bps in 2022 against a maximum downside of 662756 bps in 2022.
- Scynexis' EBIT Margin stood at 5152.43% in 2021, then sank by 129 bps to 1475.13% in 2022, then soared by 73 bps to 397.88% in 2023, then plunged by 107 bps to 824.26% in 2024, then jumped by 116 bps to 132.95% in 2025.
- The last three EBIT Margin figures came in at 132.95% (Q4 2025), 2516.47% (Q3 2025), and 700.95% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 132.95% |
| Sep 30, 2025 | -2,516.47% |
| Jun 30, 2025 | -700.95% |
| Mar 31, 2025 | -3,350.19% |
| Dec 31, 2024 | -824.26% |
| Sep 30, 2024 | -1,563.64% |
| Jun 30, 2024 | -1,255.03% |
| Mar 31, 2024 | -692.50% |
| Dec 31, 2023 | -397.88% |
| Sep 30, 2023 | -573.42% |
| Jun 30, 2023 | 88.63% |
| Mar 31, 2023 | -945.31% |
| Dec 31, 2022 | -1,475.13% |
| Sep 30, 2022 | -1,400.19% |
| Jun 30, 2022 | -1,643.08% |
| Mar 31, 2022 | -2,819.71% |
| Dec 31, 2021 | 5,152.43% |
| Sep 30, 2021 | -3,767.64% |
| Mar 31, 2021 | -13.23% |
| Jun 30, 2019 | -19,642.11% |